Navigation Links
CPC of America, Inc. to Explore Strategic Alternatives; Appoints FTI Capital Advisors to Assess Potential Opportunities
Date:9/29/2008

SARASOTA, Fla., Sept. 29 /PRNewswire-FirstCall/ -- CPC of America, Inc. (OTC Bulletin Board: CPCF.OB) today announced that it had retained FTI Capital Advisors, LLC, the investment banking subsidiary of FTI Consulting, Inc., to explore strategic alternatives for the Company.

As CPC of America's financial advisor, FTI Capital Advisors will report to the Board any expressions of interest from third parties seeking to pursue a possible licensing agreement or acquisition of the Company or its technology. CPC of America has authorized FTI Capital Advisors to contact parties and to report back so that the Board can evaluate any expressions of interest and determine whether a transaction would be in the best interests of shareholders. There can be no assurance that this process will result in any expressions of interest or a transaction, and the Company does not currently intend to publicly disclose further information regarding the status of its review until the process has been completed.

CPC of America also announced today that it has appointed FTI's Strategic Communications practice, FD, to provide public and investor relations counsel to the Company. One of the world's most sought-after business and financial communications consultancies, FD helps many of the world's leading organizations harness the power of communications to capitalize upon business opportunities. FD's Life Sciences group advises pharmaceutical and medical device entities ranging from global leaders to emerging, development-stage companies.

CPC of America's Chairman and CEO Rod A. Shipman notes, "CPC expects to benefit greatly from the counsel and support of FTI's consulting services in seeking to explore strategic alternatives and raise the visibility of our technology. We look forward to working with our advisors to examine and implement ways to maximize shareholder value."

About CPC

CPC of America acquires, develops and oversees the manufacturing of cardiology therapeutic devices for the diagnosis and treatment of coronary artery disease. CPC's current focus is the completion of development and testing of MedClose(TM) Vascular Closure System, an internal puncture-closing device for use in catheter laboratories. The Company is currently seeking FDA approval for MedClose(TM).

About FTI Consulting

FTI Capital Advisors and FD are part of the FTI Consulting, Inc. (NYSE: FCN) company group. FTI is a global business advisory firm dedicated to helping organizations protect and enhance enterprise value in an increasingly complex legal, regulatory and economic environment. With more than 3,000 employees located in most major business centers in the world, FTI works closely with clients every day to anticipate, illuminate, and overcome complex business challenges in areas such as investigations, litigation, mergers and acquisitions, regulatory issues, reputation management and restructuring.

FTI Capital Advisors, LLC (FINRA/SIPC) is the investment banking arm of FTI Consulting, Inc. FTI Capital Advisors leverages off the global footprint of its parent to provide its clients with access to buyers, sellers, investors and lenders worldwide.

A market leader in M&A advisory work, FD's services include financial public relations, capital markets communications, public affairs, crisis and issues management and corporate, business-to-business and business-to-consumer communications. FD is structured around specialist sector teams operating on an international basis, covering consumer industries, financial services, basic industries, business services, life sciences & healthcare, media, real estate, technology and telecommunications.


'/>"/>
SOURCE CPC of America, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Nano-Bio-Info-Cogno Revolutions to be Explored at Convergence08 Unconference - Forecaster Paul Saffo to Keynote
2. Carrington Retains Milkie/Ferguson to Explore Financial Alternatives
3. Viventia Biotech to Explore Strategic Alternatives - Reports Positive Pivotal Phase III Interim Efficacy Data
4. Verenium Explores Bacterial Genes Inside Termite Guts to Understand How Wood is Broken Down and Converted to Energy
5. Aktiv-Dry Awarded Research Grant to Explore Inhalable siRNA Dry Powder Targeting RSV
6. Global Experts Explore Entire Spectrum of Aids Vaccine Development
7. Boston Scientific to Explore Sale of Cardiac Surgery and Vascular Surgery Businesses
8. TorreyPines Therapeutics Strategically Repositions as Development Company Focusing on Three Versatile Lead Compounds
9. Alfacell Hires Advisors to Advance Strategic Alternatives
10. MonoSol Rx Granted Strategic US Patent for Thin Film Manufacturing Process
11. GlaxoSmithKline and Cellzome Announce Major Strategic Alliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... ... 23, 2017 , ... The Academy of Model Aeronautics (AMA), ... Association (UAA), the unifying voice for collegiate aviation education, are launching a joint ... and success through a STEM-based education platform. , Much like the program currently ...
(Date:6/22/2017)... , ... June 21, 2017 , ... ... office in North Carolina, and engages Timothy Reinhardt to manage the new site. ... leadership at Pfizer Inc, with his most recent role as the Director of ...
(Date:6/22/2017)... ... June 22, 2017 , ... ... specialists DST Diagnostische Systeme & Technologien GmbH, thereby expanding its product portfolio to ... from hay fever, urticaria, asthma, atopic eczema or a food allergy. Allergies are ...
(Date:6/22/2017)... ... June 22, 2017 , ... For the months ... produced a Spotlight series on “Cell Therapy Regulation” for its regenerative ... experts on the unique regulatory challenges of stem cell medical research. , Stem ...
Breaking Biology Technology:
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
(Date:3/29/2017)... the health IT company that operates the largest health ... today announced a Series B investment from BlueCross BlueShield ... investment and acquisition accelerates higi,s strategy to create the ... activities through the collection and workflow integration of ambient ... secures data today on behalf of over 36 million ...
(Date:3/24/2017)... Research and Markets has announced the addition of the "Global ... to 2025" report to their offering. ... The Global Biometric Vehicle Access System Market ... the next decade to reach approximately $1,580 million by 2025. ... for all the given segments on global as well as regional ...
Breaking Biology News(10 mins):